Mihiro Sunose

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 6 EPO patents. Top assignees: Pulmocide Limited, Carrick Therapeutics Limited, Debiopharm International, S.a.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mihiro Sunose. Retrieved from https://idiyas.com/inventor/mihiro-sunose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 47(Granted Patents)

Location History:

Nottingham Nottinghamshire, GB (2018)
Nottinghamshire, GB (2018 - 2023)
Nottingham, GB (2018 - 2024)

Company Filing History:

Carrick Therapeutics Limited

patents

1 out of 22

Debiopharm International, S.a.

Years Active: 2018-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545672 - Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof (2026-02-10),

2. 12473303 - 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino methyl]piperidin-3-ol compounds and their therapeutic use (2025-11-18),

3. 12269814 - Process for preparing a compound useful to treat mycoses (2025-04-08),

4. 11857552 - 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors (2024-01-02),

5. 11661415 - Process for preparing a compound useful to treat mycoses (2023-05-30),

6. 11008307 - Compounds which are used in the preparation of the compound of formula (I) (2021-05-18),

7. 10858345 - Process for preparing a compound useful to treat mycoses (2020-12-08),

8. 10800762 - Compounds which are used in the preparation of the compound of formula (II) (2020-10-13),

9. 10662179 - Process for preparing a compound useful to treat mycoses (2020-05-26),

10. 10513511 - Aqueous suspension formulation comprising 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl) or a pharmaceutically acceptable salt thereof (2019-12-24),

11. 10487073 - Compounds which are used in the preparation of the compound of formula (I) (2019-11-26),

12. 10450304 - Compound useful to treat mycoses (2019-10-22),

13. 10344022 - Compound useful to treat mycoses (2019-07-09),

14. 10280155 - Process for preparing 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-N-((1S,2S)-2-hydroxycyclohexyl) benzamide or a pharmaceutically acceptable salt thereof (2019-05-07),

15. 10106531 - Compound useful to treat mycoses (2018-10-23),

Title: Inventor Mihiro Sunose - Revolutionizing Technology in Nottingham

Introduction: Mihiro Sunose is a visionary inventor based in Nottingham, GB, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sunose holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Sunose has worked with leading tech companies and research institutions to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Sunose has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and creativity that has led to numerous successful projects.

Conclusion: Mihiro Sunose's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Nottingham and beyond.

Profile summary based on public USPTO records.